Post radical prostatectomy (RP) PSA outcomes following 6 versus 18 months of perioperative androgen receptor signaling inhibitors (ARSI) in men with localized high-risk prostate cancer: Results of Part 2 of a randomized phase 2 trial Meeting Abstract
| Authors: | McKay, R. R.; Xie, W.; Yang, X.; Acosta, A.; Rathkopf, D. E.; Laudone, V. P.; Bubley, G.; Einstein, D. J.; Chang, P. T.; Wagner, A.; Kane, C. J.; Preston, M. A.; Kilbridge, K. L.; Chang, S. L.; Choudhury, A. D.; Pomerantz, M.; Trinh, Q. D.; Kibel, A. S.; Taplin, M. E. |
| Abstract Title: | Post radical prostatectomy (RP) PSA outcomes following 6 versus 18 months of perioperative androgen receptor signaling inhibitors (ARSI) in men with localized high-risk prostate cancer: Results of Part 2 of a randomized phase 2 trial |
| Meeting Title: | 2024 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2024 Jan 25-27 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-02-01 |
| Language: | English |
| ACCESSION: | WOS:001266676900369 |
| DOI: | 10.1200/JCO.2024.42.4_suppl.326 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 326 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work